# Oscar Health, Inc.: filings

OSCR · NYSE · CIK 1568651 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/oscr.md) · [Financials](/companies/oscr/financials.md) · [Filings](/companies/oscr/filings.md) · [Insiders](/companies/oscr/insiders.md)

## Reports and events: 99 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 281, 144 90, 8-K 62, 3 31, SC 13G/A 20, 10-Q 17, SC 13G 10, S-8 9, DEFA14A 6, 10-K 5, CORRESP 5, DEF 14A 5, UPLOAD 5, ARS 4, D 4, SCHEDULE 13G/A 4, 4/A 3, DRSLTR 3, S-1/A 3, SC 13D/A 3, DRS/A 2, 10-K/A 1, 424B4 1, 5 1, 8-A12B 1, CERT 1, DRS 1, EFFECT 1, S-1 1, S-1MEF 1, SC 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-18 | 00:18 ET | [SCHEDULE 13D/A](/filings/0001193125-26-395843.md) | Ownership report, active investor, amended | 0001193125-26-395843 |
| 2026-09-16 | 10:02 ET | [8-K](/filings/0001568651-26-000074.md) | 7.01 Regulation FD disclosure | 0001568651-26-000074 |
| 2026-08-07 | 21:39 ET | [10-Q](/filings/0001568651-26-000069.md) | Quarterly report, period 2026-06-30 | 0001568651-26-000069 |
| 2026-08-06 | 10:08 ET | [8-K](/filings/0001568651-26-000066.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-26-000066 |
| 2026-06-09 | 20:11 ET | [8-K](/filings/0001568651-26-000059.md) | 5.07 Shareholder vote results | 0001568651-26-000059 |
| 2026-06-08 | 10:29 ET | [8-K](/filings/0001568651-26-000054.md) | 7.01 Regulation FD disclosure | 0001568651-26-000054 |
| 2026-06-02 | 10:31 ET | [8-K](/filings/0001568651-26-000048.md) | 5.02 Departure or appointment of officers or directors | 0001568651-26-000048 |
| 2026-05-07 | 20:24 ET | [10-Q](/filings/0001568651-26-000040.md) | Quarterly report, period 2026-03-31 | 0001568651-26-000040 |
| 2026-05-06 | 10:19 ET | [8-K](/filings/0001568651-26-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-26-000036 |
| 2026-04-22 | 20:16 ET | [DEF 14A](/filings/0001140361-26-016119.md) | Proxy statement, period 2026-06-04 | 0001140361-26-016119 |
| 2026-04-21 | 10:56 ET | [8-K](/filings/0001568651-26-000028.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001568651-26-000028 |
| 2026-03-02 | 11:41 ET | [8-K](/filings/0001568651-26-000014.md) | 7.01 Regulation FD disclosure | 0001568651-26-000014 |
| 2026-02-13 | 21:27 ET | [10-K](/filings/0001568651-26-000011.md) | Annual report, period 2025-12-31 | 0001568651-26-000011 |
| 2026-02-10 | 11:25 ET | [8-K](/filings/0001568651-26-000008.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001568651-26-000008 |
| 2025-12-29 | 21:05 ET | [8-K](/filings/0001193125-25-335294.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-335294 |
| 2025-11-06 | 21:35 ET | [10-Q](/filings/0001568651-25-000037.md) | Quarterly report, period 2025-09-30 | 0001568651-25-000037 |
| 2025-11-06 | 11:10 ET | [8-K](/filings/0001568651-25-000035.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001568651-25-000035 |
| 2025-09-18 | 20:15 ET | [8-K](/filings/0001193125-25-207417.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-207417 |
| 2025-09-16 | 10:10 ET | [8-K](/filings/0001193125-25-204231.md) | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-204231 |
| 2025-09-15 | 20:07 ET | [8-K](/filings/0001193125-25-203549.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-203549 |
| 2025-09-03 | 10:30 ET | [8-K](/filings/0001193125-25-194448.md) | 7.01 Regulation FD disclosure | 0001193125-25-194448 |
| 2025-08-07 | 20:13 ET | [10-Q](/filings/0001568651-25-000025.md) | Quarterly report, period 2025-06-30 | 0001568651-25-000025 |
| 2025-08-06 | 10:06 ET | [8-K](/filings/0001568651-25-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-25-000021 |
| 2025-07-22 | 10:06 ET | [8-K](/filings/0001568651-25-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-25-000018 |
| 2025-06-06 | 20:05 ET | [8-K](/filings/0001193125-25-137039.md) | 5.07 Shareholder vote results | 0001193125-25-137039 |
| 2025-05-08 | 23:11 ET | [10-Q](/filings/0001568651-25-000015.md) | Quarterly report, period 2025-03-31 | 0001568651-25-000015 |
| 2025-05-07 | 10:24 ET | [8-K](/filings/0001568651-25-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-25-000012 |
| 2025-04-25 | 12:00 ET | [DEF 14A](/filings/0001140361-25-015601.md) | Proxy statement, period 2025-06-04 | 0001140361-25-015601 |
| 2025-03-03 | 11:46 ET | [8-K](/filings/0001193125-25-043364.md) | 7.01 Regulation FD disclosure | 0001193125-25-043364 |
| 2025-02-20 | 21:06 ET | [10-K](/filings/0001568651-25-000008.md) | Annual report, period 2024-12-31 | 0001568651-25-000008 |
| 2025-02-04 | 21:07 ET | [8-K](/filings/0001568651-25-000005.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001568651-25-000005 |
| 2024-11-13 | 02:24 ET | [SC 13D/A](/filings/0001193125-24-257647.md) | Ownership report, active investor, amended | 0001193125-24-257647 |
| 2024-11-07 | 21:11 ET | [10-Q](/filings/0001568651-24-000032.md) | Quarterly report, period 2024-09-30 | 0001568651-24-000032 |
| 2024-11-07 | 11:10 ET | [8-K](/filings/0001568651-24-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-24-000029 |
| 2024-09-04 | 10:30 ET | [8-K](/filings/0001193125-24-212607.md) | 7.01 Regulation FD disclosure | 0001193125-24-212607 |
| 2024-08-07 | 20:10 ET | [10-Q](/filings/0001568651-24-000023.md) | Quarterly report, period 2024-06-30 | 0001568651-24-000023 |
| 2024-08-07 | 10:03 ET | [8-K](/filings/0001568651-24-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-24-000021 |
| 2024-06-11 | 20:16 ET | [8-K](/filings/0001193125-24-159132.md) | 5.07 Shareholder vote results | 0001193125-24-159132 |
| 2024-06-07 | 10:01 ET | [8-K](/filings/0001193125-24-156438.md) | 7.01 Regulation FD disclosure | 0001193125-24-156438 |
| 2024-05-07 | 20:18 ET | [10-Q](/filings/0001568651-24-000015.md) | Quarterly report, period 2024-03-31 | 0001568651-24-000015 |
| 2024-05-07 | 10:10 ET | [8-K](/filings/0001568651-24-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-24-000013 |
| 2024-04-25 | 12:12 ET | [DEF 14A](/filings/0001140361-24-021911.md) | Proxy statement, period 2024-06-06 | 0001140361-24-021911 |
| 2024-02-15 | 21:06 ET | [10-K](/filings/0001568651-24-000006.md) | Annual report, period 2023-12-31 | 0001568651-24-000006 |
| 2024-02-07 | 21:13 ET | [8-K](/filings/0001568651-24-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-24-000004 |
| 2024-01-10 | 11:07 ET | [8-K](/filings/0001193125-24-005574.md) | 2.02 Results of operations | 0001193125-24-005574 |
| 2023-12-29 | 11:04 ET | [8-K](/filings/0001193125-23-305664.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-23-305664 |
| 2023-11-20 | 11:18 ET | [8-K](/filings/0001193125-23-280184.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-280184 |
| 2023-11-07 | 21:17 ET | [10-Q](/filings/0001568651-23-000056.md) | Quarterly report, period 2023-09-30 | 0001568651-23-000056 |
| 2023-11-07 | 11:11 ET | [8-K](/filings/0001568651-23-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001568651-23-000054 |
| 2023-09-11 | 10:06 ET | [8-K](/filings/0001193125-23-231903.md) | 7.01 Regulation FD disclosure | 0001193125-23-231903 |

Page 1 of 2. [Older](/companies/oscr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.